DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Prospective Stuy in Evaluating Hepatic Fibrosis Related to Hepatitis B Virus Using Non-invasive Parameters

Information source: Peking University First Hospital
ClinicalTrials.gov processed this data on August 20, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Hepatitis B; Liver Fibrosis

Phase: N/A

Status: Recruiting

Sponsored by: Peking University First Hospital

Official(s) and/or principal investigator(s):
Guiqiang Wang, Principal Investigator, Affiliation: Peking University First Hospital

Overall contact:
Guiqiang Wang, Phone: 13911405123, Email: john131212@126.com


The aim of our prospective study is to construct and validate a non-invasive model consisting biochemical markers, FibroScan, and radiological parameters for evaluating liver fibrosis caused by hepatitis B virus in mainland China.

Clinical Details

Official title: Prospective Stuy in Evaluating Hepatic Fibrosis Related to Hepatitis B Virus

Study design: Observational Model: Cohort, Time Perspective: Prospective

Primary outcome: determine whether a non-invasive test or a combination of non invasive tests may be used to accurately evaluate liver fibrosis in patients with chronic hepatitis B


Minimum age: 18 Years. Maximum age: 65 Years. Gender(s): Both.


Inclusion Criteria: 1. HBsAg positive for at least 6 months 2. agree to have liver biopsy 3. Male or female aged 18 to 65 years old Exclusion Criteria: 1. Patients with alcoholic liver disease, autoimmune liver disease, heretic liver disease, drug induced liver disease,nonalcoholic liver disease or other chronic liver disease 2. platelet count < 80000/L 3. prothrombin activity ≤ 60% 4. patients with any disease or condition which the investigator or treating physician feels would interfere with the trial or the safety of the subject

Locations and Contacts

Guiqiang Wang, Phone: 13911405123, Email: john131212@126.com

Beijing Youan Hospital, Capital Medical University, Beijing, China; Recruiting
Jun Lv, Phone: 13661381489, Email: lujun98@ccmu.edu.com
Jun Lv, Principal Investigator

China-Japan Friendship Hospital, Beijing, China; Recruiting
Anlin Ma, Phone: 13910253710, Email: maanlinjc@163.com
Anlin Ma, Principal Investigator

The 305 Hospital of People's Liberation Army, Beijing, China; Recruiting
Zhijin Wang, Phone: 15301018578
Zhijin Wang, Principal Investigator

West China Hospital, Sichuan University, Chengdu, China; Recruiting
Liang Bai, Phone: 86-18980602254, Email: pangbailang@163.com
Liang Bai, Principal Investigator

Shanghai Public Health Clinical Center, Shanghai, China; Recruiting
Zhanqing Zhang, Phone: 18916039958, Email: doctorzzqsphc@163.com
Zhanqing Zhang, Principal Investigator

Shanghai Ruijin Hospital, Shanghai, China; Recruiting
Qing Xie, Phone: 13651804273, Email: xieqingrjh@163.com
Qing Xie, Principal Investigator

The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China; Recruiting
Jiabin Li, Phone: 13855148570, Email: lijiabin948@163.com
Jiabin Li, Principal Investigator

Peking University First Hospital, Bei Jing, Beijing 100034, China; Recruiting
Guiqiang Wang, MD, Phone: 86-13911405123, Email: john131212@hotmail.com
Hong Zhao, MD, Phone: 86-13810765942, Email: minmin2001@gmail.com
Guiqiang Wang, MD, Principal Investigator

302 Military Hospital of China, Beijing, Beijing 100000, China; Recruiting
Liming Chen, MD, Phone: 86-13021293636, Email: hm160@sina.cn
LiMing Chen, MD, Principal Investigator

Beijing Ditan Hospital, Beijing, Beijing 10000, China; Recruiting
Jun Cheng, MD, Phone: 86-10-64281540, Email: jun.cheng@bjditan.org
Jun Cheng, MD, Principal Investigator

Southwest Hospital, Third Military Medical University, Chongqing, Chongqing, China; Recruiting
Xuqing Zhang, Phone: 86-13527485619, Email: xuqing651005@tom.com
Xuqing Zhang, Principal Investigator

The Second Affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing, China; Recruiting
Dazhi Zhang, MD, Phone: 86-13452382818, Email: zhangdzh@etang.com
Dazhi Zhang, Principal Investigator

Guangzhou Eighth People's Hospital, Guangzhou, Guangdong, China; Recruiting
Xiaobing Hu, Phone: 13711307178, Email: Dr.HXB@163.com
Xiaobing Hu, Principal Investigator

The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China; Recruiting
Shibin Xie, MD, Phone: 86-13922244948, Email: xieshibin1964@163.com
Shibin Xie, Principal Investigator

The Third people's Hospital of Shenzhen, Shenzhen, Guangdong, China; Recruiting
Yingxia Liu, Phone: 13603096453, Email: yingxialiu@hotmail.com
Yingxia Liu, Principal Investigator

The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China; Recruiting
Guo Zhang, Phone: 13978839646, Email: zhangguogx@hotmail.com
Guo Zhang, Principal Investigator

The Third People's Hospital of Qinhuangdao, Qinhuangdao, Hebei, China; Recruiting
Xun Peng, Phone: 18603361960, Email: pengxun1960@163.com
Xun Peng, Principal Investigator

The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, China; Recruiting
Weifeng Zhao, Phone: 13837313280, Email: zwf7577@126.com
Weifeng Zhao, Principal Investigator

Henan Provincial People's Hospital, Zhengzhou, Henan, China; Recruiting
Jia Shang, Phone: 13938401888, Email: shangjia666@126.com
Jia Shang, Principal Investigator

Renmin Hospital of Wuhan University, Wuhan, Hubei, China; Recruiting
Zuojiong Gong, Phone: 13971687857, Email: zjgong@163.com
Zuojiong Gong, Principal Investigator

Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China; Recruiting
Wangxian Tang, Phone: 15907118789, Email: tangwx@tjh.tjmu.edu.cn
Wangxian Tang, Principal Investigator

The Second Xiangya Hospital of Central South Hospital, Changsha, Hunan, China; Recruiting
Guozhong Gong, Phone: 13873104819, Email: guozhonggong@yahoo.com
Guozhong Gong, Principal Investigator

81 Military Hospital of China, Nanjing, Jiangsu, China; Recruiting
Maorong Wang, Phone: 13401935666, Email: maorongwang@126.com
Maorong Wang, Principal Investigator

The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China; Recruiting
Jun Li, Phone: 13905175333, Email: prof.lijun@gmail.com
Jun Li, Principal Investigator

The Second Hospital of Nanjing, Nanjing, Jiangsu, China; Recruiting
Wei Zhao, Phone: 13951901772
Wei Zhao, Principal Investigator

Dalian the Sixth People's Hospital, Dalian, Liaoning, China; Recruiting
Wanli Sun, Phone: 13898657676
Wanli Sun, Principal Investigator

The Sixth People's Hospital of Shenyang, Shenyang, Liaoning, China; Recruiting
Mingxiang Zhang, Phone: 13386868855, Email: zmx6511@126.com
Mingxiang Zhang, Principal Investigator

Yantai City Hospital for Infectious Diseases, Yantai, Shandong, China; Recruiting
Zhiqiang Zhou, Phone: 13306387366, Email: zhiqiangzou@126.com
Zhiqiang Zhou, Principal Investigator

Shan Xi Medical University, Taiyuan, Shanxi, China; Recruiting
Longfeng Zhao, Phone: 13934519086
Longfeng Zhao, Principal Investigator

Zhejiang First Hospital, Hang Zhou, Zhejiang, China; Recruiting
Weifeng Liang, MD, Phone: 86-13957163061, Email: dr.liangwf@163.com
Weifeng Liang, Principal Investigator

Additional Information

Starting date: August 2013
Last updated: November 28, 2014

Page last updated: August 20, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017